PuSH - Publication Server of Helmholtz Zentrum München

27 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Hung, R.J.* et al.: Lung cancer risk in never smokers of European descent is associated with genetic variation in the 5P15.33 TERT-CLPTM1L Region. J. Thorac. Oncol., accepted (2019)
2.
Zhu, Y.* et al.: Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis. Cancer Epidemiol. Biomarkers Prev. 28, 935-942 (2019)
3.
Feng, Y.* et al.: Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol. Carcinog. 57, 216-224 (2018)
4.
Feng, Y.* et al.: Genetic variants of PTPN2 are associated with lung cancer risk: A re-analysis of eight GWASs in the TRICL-ILCCO consortium. Sci. Rep. 7:825 (2017)
5.
Gu, F.* et al.: Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. Int. J. Cancer 141, 1794-1802 (2017)
6.
Liu, H.* et al.: Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis 38, 541-551 (2017)
7.
McKay, J.D.* et al.: Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat. Genet. 49, 1126-1132 (2017)
8.
Melin, B.S.* et al.: Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat. Genet. 49, 789-794 (2017)
9.
Pan, Y.* et al.: Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: A pathway-based analysis from published GWASs. Sci. Rep. 7:44634 (2017)
10.
Yin, J.* et al.: Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol. Carcinog. 56, 1663-1672 (2017)
11.
Zhou, F.S.* et al.: Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk - a re-analysis of eight GWASs. Mol. Carcinog. 56, 1227-1238 (2017)
12.
Zuber, V.* et al.: Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer. BMC Genomics 18:270 (2017)
13.
Fehringer, G.* et al.: Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations. Cancer Res. 76, 5103-5114 (2016)
14.
Kang, X.* et al.: Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: A meta-analysis of 14 463 cases and 44 188 controls. Carcinogenesis 37, 280-289 (2016)
15.
Patel, Y.M.* et al.: Novel association of genetic markers affecting CYP2A6 activity and lung cancer risk. Cancer Res. 76, 5768-5776 (2016)
16.
Yuan, H.M.* et al.: A novel genetic variant in long non-coding RNA gene NEXN-AS1 is associated with risk of lung cancer. Sci. Rep. 6:34234 (2016)
17.
Interleukin 1 Genetics Consortium et al.: Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: A mendelian randomisation analysis. Lancet Diabet. Endocrinol. 3, 243-253 (2015)
18.
Brenner, D.R.* et al.: Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis 36, 1314-1326 (2015)
19.
Kinnersley, B.* et al.: Genome-wide association study identifies multiple susceptibility loci for glioma. Nat. Commun. 6:8559 (2015)
20.
Kinnersley, B.* et al.: Quantifying the heritability of glioma using genome-wide complex trait analysis. Sci. Rep. 5:17267 (2015)